Reaction Details Report a problem with these data
Target
Mu-type opioid receptor
Ligand
BDBM438867
Substrate
n/a
Meas. Tech.
Competitive Displacement Assay
Ki
<1±n/a nM
Citation
 Wynn, TA; Alvarez, JC; Moustakas, DT; Haeberlein, M; Pennington, LD Compounds for the treatment of pain US Patent  US10604489 Publication Date 3/31/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM438867
Synonyms:
3-((1R,5S,9r)-3-butyl-9-methoxy-3-azabicyclo[3.3.1]nonan-9-yl)benzamide hydrochloride | US10604489, Compound 29 | US11180455, Compound 29
Type:
Small organic molecule
Emp. Form.:
C20H30N2O2
Mol. Mass.:
330.4644
SMILES:
CCCCN1CC2CCCC(C1)C2(OC)c1cccc(c1)C(N)=O |TLB:15:12:8.7.9:11.5.4,THB:3:4:12:8.7.9,13:12:8.7.9:11.5.4|
Structure:
Search PDB for entries with ligand similarity: